Mark W. Frohlich

2014

In 2014, Mark W. Frohlich earned a total compensation of $2M as Executive Vice President, Portfolio Strategy at Juno Therapeutics.

Compensation breakdown

Bonus$200,000
Non-Equity Incentive Plan$108,000
Salary$366,667
Stock Awards$1,375,000
Total$2,049,667

Frohlich received $1.4M in stock awards, accounting for 67% of the total pay in 2014.

Frohlich also received $200K in bonus, $108K in non-equity incentive plan and $366.7K in salary.

Rankings

In 2014, Mark W. Frohlich's compensation ranked 4,420th out of 13,032 executives tracked by ExecPay. In other words, Frohlich earned more than 66.1% of executives.

ClassificationRankingPercentile
All
4,420
out of 13,032
66th
Division
Manufacturing
1,576
out of 4,966
68th
Major group
Chemicals And Allied Products
519
out of 1,686
69th
Industry group
Drugs
399
out of 1,365
71st
Industry
Biological Products, Except Diagnostic Substances
69
out of 236
71st
Source: SEC filing on April 20, 2016.

Frohlich's colleagues

We found two more compensation records of executives who worked with Mark W. Frohlich at Juno Therapeutics in 2014.

2014

Hans Bishop

Juno Therapeutics

Chief Executive Officer

2014

Steven Harr

Juno Therapeutics

Chief Financial Officer

You may also like